newsfilter
← Latest News
GlobeNewswire·

VBL Therapeutics to Present at H.C. Wainwright BioConnect Virtual Conference

TEL AVIV, Israel and NEW YORK, Jan. 06, 2022 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT), a clinical stage biotechnology company developing first-in-class therapeutics for difficult-to-treat malignant solid tumors and immune-inflammatory indicat